Literature DB >> 29610198

Pharmacokinetics of Daptomycin in Critically Ill Pediatric Patients.

Charalampos Antachopoulos1, Stavroula Ilia2, Paschalis Kadiltzoglou1, Eirini Baira3, Aristides Dokoumetzidis3, Evangelos Gikas3, Eleni Volakli4, Maria Sdougka4, George Briassoulis2, Emmanuel Roilides5.   

Abstract

The pharmacokinetics of daptomycin (10 mg/kg once daily) was studied in 4 critically ill pediatric patients aged 8 to 14 yrs. The area under the concentration-time curve from time zero to infinity (AUC0-∞) of plasma concentrations on day 1 ranged between 123.8 to 663.9 μg · h/ml, with lower values observed in septic and burn patients; clearance ranged from 15.1 to 80.7 ml/h/kg. Higher-than-recommended doses of daptomycin may be needed in septic children to ensure optimal drug exposure. Interpatient variability may suggest a role for therapeutic drug monitoring.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  burn; children; critically ill; daptomycin; pharmacokinetics; sepsis

Mesh:

Substances:

Year:  2018        PMID: 29610198      PMCID: PMC5971567          DOI: 10.1128/AAC.02462-17

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  Single-dose pharmacokinetics of daptomycin in pediatric patients 3-24 months of age.

Authors:  John S Bradley; David Benziger; Paula Bokesch; Richard Jacobs
Journal:  Pediatr Infect Dis J       Date:  2014-09       Impact factor: 2.129

2.  Population pharmacokinetics of daptomycin in patients affected by severe Gram-positive infections.

Authors:  Antonello Di Paolo; Carlo Tascini; Marialuisa Polillo; Giulia Gemignani; Elisabet I Nielsen; Guido Bocci; Mats O Karlsson; Francesco Menichetti; Romano Danesi
Journal:  Int J Antimicrob Agents       Date:  2013-07-25       Impact factor: 5.283

3.  Pediatric risk of mortality (PRISM) score.

Authors:  M M Pollack; U E Ruttimann; P R Getson
Journal:  Crit Care Med       Date:  1988-11       Impact factor: 7.598

Review 4.  International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics.

Authors:  Brahm Goldstein; Brett Giroir; Adrienne Randolph
Journal:  Pediatr Crit Care Med       Date:  2005-01       Impact factor: 3.624

5.  Pharmacokinetics and tolerability of daptomycin at doses up to 12 milligrams per kilogram of body weight once daily in healthy volunteers.

Authors:  Mark Benvenuto; David P Benziger; Sara Yankelev; Gloria Vigliani
Journal:  Antimicrob Agents Chemother       Date:  2006-10       Impact factor: 5.191

6.  Daptomycin for Complicated Skin Infections: A Randomized Trial.

Authors:  John Bradley; Chad Glasser; Hernando Patino; Sandra R Arnold; Antonio Arrieta; Blaise Congeni; Robert S Daum; Tsoline Kojaoghlanian; Minjung Yoon; Diane Anastasiou; Dominik J Wolf; Paula Bokesch
Journal:  Pediatrics       Date:  2017-02-15       Impact factor: 7.124

7.  Considerations for higher doses of daptomycin in critically ill patients with methicillin-resistant Staphylococcus aureus bacteremia.

Authors:  Marco Falcone; Alessandro Russo; Mario Venditti; Andrea Novelli; Manjunath P Pai
Journal:  Clin Infect Dis       Date:  2013-09-17       Impact factor: 9.079

8.  Single-dose pharmacokinetics of daptomycin in children with suspected or proved gram-positive infections.

Authors:  Susan M Abdel-Rahman; David P Benziger; Richard F Jacobs; Hasan S Jafri; Erica Fischer Hong; Gregory L Kearns
Journal:  Pediatr Infect Dis J       Date:  2008-04       Impact factor: 2.129

Review 9.  Advances in antibiotic therapy in the critically ill.

Authors:  Jean-Louis Vincent; Matteo Bassetti; Bruno François; George Karam; Jean Chastre; Antoni Torres; Jason A Roberts; Fabio S Taccone; Jordi Rello; Thierry Calandra; Daniel De Backer; Tobias Welte; Massimo Antonelli
Journal:  Crit Care       Date:  2016-05-17       Impact factor: 9.097

Review 10.  Daptomycin: an evidence-based review of its role in the treatment of Gram-positive infections.

Authors:  Armando Gonzalez-Ruiz; R Andrew Seaton; Kamal Hamed
Journal:  Infect Drug Resist       Date:  2016-04-15       Impact factor: 4.003

View more
  2 in total

1.  Pharmacokinetics and Target Attainment of Antibiotics in Critically Ill Children: A Systematic Review of Current Literature.

Authors:  Stan J F Hartman; Roger J Brüggemann; Lynn Orriëns; Nada Dia; Michiel F Schreuder; Saskia N de Wildt
Journal:  Clin Pharmacokinet       Date:  2020-02       Impact factor: 6.447

2.  Multi-site infection by methicillin-resistant Staphylococcus aureus in a six-year old girl: a case report.

Authors:  Pei Xiao; Jing Liu; Xue Yang; Yixue Wang; Weiming Chen; Chuanqing Wang; Qian Liu; Quanli Shen; Guoping Lu; Gangfeng Yan
Journal:  BMC Infect Dis       Date:  2022-03-03       Impact factor: 3.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.